Drongen, Belgium

Karen Saerens

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Ghent. Active years: 2015.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karen Saerens: Innovator in Yeast Biotechnology

Introduction

Karen Saerens is a prominent inventor based in Drongen, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of yeast species for industrial applications. Her innovative work focuses on modifying yeast strains to enhance their utility in producing valuable compounds.

Latest Patents

Karen Saerens holds a patent related to yeast species that are capable of producing sophorolipids but have been modified to be incapable of producing these compounds. This invention reveals that the sophorolipid-negative strains exhibit growth characteristics and biomass formation comparable to their wild-type counterparts. These modified strains are particularly useful for the production of recombinant proteins, glycolipids, polyhydroxyalkanoates, and carotenoids. Additionally, her patent discloses two glucosyltransferase genes that play key roles in sophorolipid production.

Career Highlights

Karen is affiliated with the University of Ghent, where she conducts her research and development activities. Her work has garnered attention for its potential applications in various biotechnological fields.

Collaborations

Throughout her career, Karen has collaborated with notable colleagues, including Sophie Roelants and Wim Soetaert. These partnerships have contributed to the advancement of her research and the successful implementation of her inventions.

Conclusion

Karen Saerens is a trailblazer in yeast biotechnology, with a focus on innovative modifications that enhance the production of valuable compounds. Her contributions to the field are significant and continue to influence biotechnological advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…